Sunnybrook Health Sciences Centre: Clinical Trials

740 trials sponsored by Sunnybrook Health Sciences Centre, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

330 completed, 162 unknown, 110 recruiting, 47 active not recruiting. 400 Not applicable, 97 Phase 2, 56 Phase 3, 49 Phase 1, 31 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable400Completed 176, Unknown 97, Recruiting 52, Active not recruiting 29, Not yet recruiting 20, Terminated 17, Withdrawn 6, Suspended 2, Enrolling by invitation 1
Phase 297Completed 39, Unknown 18, Recruiting 17, Terminated 11, Active not recruiting 6, Withdrawn 3, Not yet recruiting 2, Suspended 1
Phase 356Completed 31, Recruiting 8, Unknown 5, Not yet recruiting 4, Terminated 3, Withdrawn 3, Active not recruiting 2
Phase 149Completed 18, Recruiting 9, Unknown 9, Active not recruiting 4, Terminated 4, Withdrawn 3, Enrolling by invitation 1, Suspended 1
Phase 431Completed 16, Unknown 7, Recruiting 5, Terminated 2, Active not recruiting 1
Early Phase 17Completed 4, Unknown 2, Not yet recruiting 1

Follow Sunnybrook Health Sciences Centre: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perforated Appendicitis and Postoperative Antibiotics Pilot Trial
Postoperative antibiotico-prophylaxis, No postoperative antibiotics - Perforated Appendicitis
Not applicableNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1002027-01-012026-09-17
Assessing Heart and Brain Metabolism in Type II Diabetes Mellitus Patients Using Carbon-13 MRI
C13 Hyperpolarized pyruvate injection - Diabete Type 2
Early Phase 1Not yet recruitingSunnybrook Health Sciences Centre322026-10-012026-09-15
Ketogenic Diet and Neuromodulation in Treatment Resistant Depression
Accelerated Intermittent Theta Burst Stimulation (iTBS), Ketogenic Diet, Canadian Food Guide-Aligned Diet - Major Depressive Disorder (MDD), Treatment Resistant Depression (TRD)
Not applicableNot yet recruitingSunnybrook Health Sciences Centre602026-10-012026-09-25
Better Access to and Integration of Mental Health and Addiction Services Through Navigation: A Mixed-Methods Adaptive Pragmatic Clinical Trial
Family Navigation Project - Mental Health, Addictions
Not applicableNot yet recruitingSunnybrook Health Sciences Centre4802026-10-012026-07-16
Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
Eptinezumab, Placebo - Post Traumatic Headache
Phase 3Not yet recruitingSunnybrook Health Sciences Centre802026-09-302026-08-13
Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older
Stethophone - Moderate or Severe Aortic Stenosis
Not applicableNot yet recruitingSunnybrook Health Sciences Centre10002026-09-012026-09-18
CEST for Prostate Biopsy
Biopsy-Guided Therapy Selection - Prostate Cancer Detection
Not applicableNot yet recruitingSunnybrook Health Sciences Centre202026-09-012026-08-25
Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)
Early goal-directed Cardio-Kidney-Metabolic (CKM) care, Standard care (Comparison arm) - Diabetic Kidney Disease (DKD), Type 2 Diabetes Mellitus (T2DM)
Not applicableRecruitingSunnybrook Health Sciences Centre1002026-08-262026-09-04
Erector Spinae Plane vs Serratus Anterior Plane Catheter Infusions for Acute Pain Management in Patients With Traumatic Rib Fractures
Erector spinae plane catheter, Serratus plane catheter - Traumatic Rib Fracture(s), Traumatic Rib Fracture
Not applicableNot yet recruitingSunnybrook Health Sciences Centre662026-08-012026-08-10
Safety and Feasibility of Next-Generation Dome Helmet (NGDH) for Focused Ultrasound Neuromodulation in Substance Use Disorder (SUD)
Next Generation Dome Helmet (NGDH) - Substance Use Disorder (SUD)
Not applicableRecruitingSunnybrook Health Sciences Centre202026-07-012026-07-06
Neuromodulation and fMRI in Neurodegenerative Diseases Study
Transcranial Alternating Current Stimulation - Mild Cognitive Impairment, Traumatic Brain Injury
Not applicableNot yet recruitingSunnybrook Health Sciences Centre302026-06-012026-05-01
InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression
Ketamine, Oculus VR headset - Treatment Resistant Depression
Phase 3RecruitingSunnybrook Health Sciences Centre312026-05-032026-08-13
Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging
ctDNA-guided imaging surveillance, Standard - Triple Negative Breast Cancer, Surveillance
Not applicableNot yet recruitingSunnybrook Health Sciences Centre302026-05-012026-03-17
This Study Will Use Real-time Pressure Mapping Technology to Determine Which Positioning Strategies and Devices Exert the Least Amount of Pressure on Peri-operative Burn Patients
Positioning and positioning devices - Hospital Acquired Pressure Injury
Not applicableNot yet recruitingSunnybrook Health Sciences Centre802026-05-012026-05-05
Baseline Knowledge of Stress Urinary Incontinence Among Urogynecology Patients
15 Item Questionnaire - Stress Urinary Incontinence (SUI)
Not yet recruitingSunnybrook Health Sciences Centre902026-04-302026-04-28
Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares
Glucocorticoid (GC) - Rheumatoid Arthritis (RA)
Phase 4RecruitingSunnybrook Health Sciences Centre2202026-04-012026-04-13
A Phase II Trial Evaluating Radiation Boost to Painful Spinal Metastases
Radiation Boost - Spine Metastasis
Phase 2RecruitingSunnybrook Health Sciences Centre1082026-04-012026-03-17
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
Edoxaban 15 mg, Aspirin or clopidogrel - Stroke, Ischemic
Phase 3Not yet recruitingSunnybrook Health Sciences Centre12042026-04-012026-03-06
A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer
Enzalutamide Dose Escalation, Standard of Care - Prostate Cancer Patients, Elderly Patients
Phase 2Not yet recruitingSunnybrook Health Sciences Centre262026-04-012026-04-06
Dose-dEscalated MR-Guided Radiotherapy for Localized Prostate Cancer
Prostate radical radiotherapy - Intermediate Risk Prostate Cancer (Diagnosis), Prostate Cancer
Not applicableActive not recruitingSunnybrook Health Sciences Centre242026-03-222026-09-03

Showing 20 of 740. Sign in to see all of them.

Conditions studied

Breast Neoplasms (47)  ·  Prostatic Neoplasms (44)  ·  Depression (29)  ·  Stroke (27)  ·  Anxiety Disorders (22)  ·  Depressive Disorder, Major (22)  ·  Cognitive Dysfunction (20)  ·  Alzheimer Disease (19)  ·  Neoplasms (19)  ·  Hypertension (16)  ·  Premature Birth (16)  ·  Arthritis (13)  ·  Bipolar Disorder (13)  ·  COVID-19 (13)  ·  Cardiovascular Diseases (13)

Interventions

Therapeutics (12)  ·  Radiosurgery (11)  ·  Exercise (9)  ·  Standard of Care (9)  ·  Saline Solution (8)  ·  Sodium Chloride (8)  ·  Transcranial Magnetic Stimulation (8)  ·  Transcranial Direct Current Stimulation (6)  ·  Injections (5)  ·  Citalopram (4)  ·  Cognitive Behavioral Therapy (4)  ·  Deep Brain Stimulation (4)  ·  perflutren (4)  ·  Acetaminophen (3)  ·  Aspirin (3)

Countries

Canada (683)  ·  United States (28)  ·  Australia (8)  ·  Germany (6)  ·  Israel (6)  ·  United Kingdom (6)  ·  Italy (5)  ·  Netherlands (4)  ·  New Zealand (4)  ·  Spain (4)  ·  Austria (3)  ·  Brazil (3)  ·  Denmark (3)  ·  Ireland (3)  ·  Belgium (2)

Top investigators

Mary J Bell, MD, FRCPC (8)  ·  Andrew Loblaw, MD (7)  ·  Gregory J Czarnota, PhD, MD (7)  ·  Nathan Herrmann, MD (7)  ·  Charles Cunningham, PhD (6)  ·  Paul Karanicolas, MD PhD (6)  ·  Nick Daneman, MD (5)  ·  David M Kreindler, MD (4)  ·  Edward LW Chow, MBBS (4)  ·  Eric Leung, MD (4)  ·  Krista L Lanctot, PhD (4)  ·  Krista Lanctot, PhD (4)  ·  Michael Dunn, MD (4)  ·  Sandra Black, MD (4)

Results publications

PMID 23457326, PMID 27622157, PMID 33067379, PMID 35504244, PMID 37419394, PMID 37619656, PMID 39901803, PMID 41506574, PMID 10194512, PMID 10355863, PMID 10396491, PMID 10718232, PMID 10866248, PMID 11112239, PMID 11510598, PMID 12634549, PMID 14625335, PMID 15327808, PMID 15564545, PMID 15729413, PMID 15941430, PMID 16182464, PMID 16527791, PMID 17156107, PMID 17257413, PMID 17540020, PMID 17635708, PMID 17635709, PMID 17877830, PMID 17915028, PMID 18285602, PMID 18465388, PMID 18591575, PMID 18664970, PMID 18759650, PMID 18784267, PMID 18840838, PMID 18930602, PMID 19068141, PMID 19078910, PMID 19426530, PMID 19718469, PMID 19817986, PMID 19923205, PMID 19930566, PMID 20006356, PMID 20082712, PMID 20110375, PMID 20124539, PMID 20146233

NIH funding

R01HD111018 (1), R01HL067939 (1), U54NS065705 (1)